Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 16822600 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| although the number of reports on autologous stem cell transplantation is still limited, the outcome seems similar to allogeneicsct with donors other than hla-identical siblings. | |||||||
| 16856932 | HLA (HLA) | fludarabine | NA | melphalan | NA | unclassified | |
| NA | |||||||
| 16856932 | HLA (HLA) | fludarabine | NA | melphalan | NA | unclassified | |
| NA | |||||||
| 17028897 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | methotrexate | NA | unclassified | |
| to evaluate whether the c677t and a1298c polymorphisms of 5,10-methylenetetrahydrofolate reductase (mthfr) are related to the toxicity of methotrexate (mtx) used in allogeneic stem cell transplantation, we performed association analysis between these genetic polymorphisms and the clinical outcomes of patients treated using human leukocyte antigen-matched sibling stem cell transplantation. | |||||||
| 17028897 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | methotrexate | NA | unclassified | |
| polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in hla-matched sibling allogeneic hematopoietic stem cell transplantation. | |||||||
| 17031690 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | idarubicin | NA | cytarabine | NA | unclassified | |
| NA | |||||||
| 17082014 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| hla-matched unrelated donor (mud) stem cell transplantation (mud) is complicated by a high incidence of graft-versus-host-disease (gvhd) resulting in significant morbidity and mortality. | |||||||
| 17084369 | HLA MATCHED (HLA-MATCHED) | busulfan | NA | fludarabine | NA | unclassified | |
| NA | |||||||
| 17088649 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| these advances have now permitted the indications for haematopoietic stem cell transplantation to be extended in primary immunodeficiencies.summarythe optimal results of haematopoietic stem cell transplantation in primary immunodeficiencies have long been obtained with related human leukocyte antigen-identical donors, an option limited to a minority of patients. | |||||||
| 17120011 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| formalin-fixed and paraffin-embedded conjunctival specimens from 23 post-mortem control eyes and 42 patients after haematopoietic stem cell transplantation (hsct) were stained with haematoxylin and eosin (he), periodic acid-schiff (pas) stain and with antibodies against cd1a, cd4, cd8, cd25, cd45ro, cd68, fas ligand, tia-1, hla-dralpha by means of immunohistochemistry. | |||||||
Copyright 2024